BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1397062)

  • 1. Discrimination between two types of P2 purinoceptors by suramin in rat hepatocytes.
    Tomura H; Okajima F; Kondo Y
    Eur J Pharmacol; 1992 Aug; 226(4):363-5. PubMed ID: 1397062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
    Boyer JL; Zohn IE; Jacobson KA; Harden TK
    Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells.
    Matsuoka I; Zhou Q; Ishimoto H; Nakanishi H
    Mol Pharmacol; 1995 Apr; 47(4):855-62. PubMed ID: 7723748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.
    Dunn PM; Blakeley AG
    Br J Pharmacol; 1988 Feb; 93(2):243-5. PubMed ID: 3359103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.
    Hoyle CH; Knight GE; Burnstock G
    Br J Pharmacol; 1990 Mar; 99(3):617-21. PubMed ID: 2331585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C; Hicks J; Salter MW
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin and reactive blue 2 are antagonists for a newly identified purinoceptor on rat megakaryocyte.
    Uneyama H; Uneyama C; Ebihara S; Akaike N
    Br J Pharmacol; 1994 Jan; 111(1):245-9. PubMed ID: 7516802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory action of suramin on the P2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci.
    den Hertog A; Nelemans A; Van den Akker J
    Eur J Pharmacol; 1989 Aug; 166(3):531-4. PubMed ID: 2806375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
    Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
    Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells. Activation of phospholipase C, and inhibition and activation of adenylate cyclase.
    Sato K; Okajima F; Kondo Y
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):281-7. PubMed ID: 1314567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electrophysiological study of excitatory purinergic neuromuscular transmission in longitudinal smooth muscle of chicken anterior mesenteric artery.
    Khalifa M; El-Mahmoudy A; Shiina T; Shimizu Y; Nikami H; El-Sayed M; Kobayashi H; Takewaki T
    Br J Pharmacol; 2005 Mar; 144(6):830-9. PubMed ID: 15685211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
    Bailey SJ; Hourani SM
    Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.
    Gonçalves J; Queiroz G
    Br J Pharmacol; 1996 Jan; 117(1):156-60. PubMed ID: 8825357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae.
    Bailey SJ; Hickman D; Hourani SM
    Br J Pharmacol; 1992 Feb; 105(2):400-4. PubMed ID: 1559130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon.
    Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
    Br J Pharmacol; 1996 Nov; 119(5):779-86. PubMed ID: 8922721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of suramin on hippocampal apyrase activity and inhibitory avoidance learning of rats.
    Bonan CD; Roesler R; Quevedo J; Battastini AM; Izquierdo I; Sarkis JJ
    Pharmacol Biochem Behav; 1999 May; 63(1):153-8. PubMed ID: 10340536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel competitive antagonists for P2 purinoceptors.
    van Rhee AM; van der Heijden MP; Beukers MW; IJzerman AP; Soudijn W; Nickel P
    Eur J Pharmacol; 1994 Jun; 268(1):1-7. PubMed ID: 7925607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinoceptors in neuromuscular transmission.
    Henning RH
    Pharmacol Ther; 1997; 74(1):115-28. PubMed ID: 9336019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.